Review



ic 50 calculation with graphpad prism 7 software  (GraphPad Software Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GraphPad Software Inc ic 50 calculation with graphpad prism 7 software
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Calculation With Graphpad Prism 7 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic 50 calculation with graphpad prism 7 software/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic 50 calculation with graphpad prism 7 software - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan"

    Article Title: A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan

    Journal: Scientific Reports

    doi: 10.1038/s41598-024-84566-y

    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of sacituzumab (anti-TROP2 antibody) or sacituzumab govitecan (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Figure Legend Snippet: Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of sacituzumab (anti-TROP2 antibody) or sacituzumab govitecan (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.

    Techniques Used: Control, CCK-8 Assay



    Similar Products

    ic 50 calculation with graphpad prism 7 software  (GraphPad Software Inc)
    90
    GraphPad Software Inc ic 50 calculation with graphpad prism 7 software
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Calculation With Graphpad Prism 7 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic 50 calculation with graphpad prism 7 software/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic 50 calculation with graphpad prism 7 software - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ic-50 calculation of graphpad prism  (GraphPad Software Inc)
    90
    GraphPad Software Inc ic-50 calculation of graphpad prism
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Calculation Of Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic-50 calculation of graphpad prism/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic-50 calculation of graphpad prism - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ic 50 of the inhibitory concentration calculated using graphpad prism  (GraphPad Software Inc)
    90
    GraphPad Software Inc ic 50 of the inhibitory concentration calculated using graphpad prism
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Of The Inhibitory Concentration Calculated Using Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic 50 of the inhibitory concentration calculated using graphpad prism/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic 50 of the inhibitory concentration calculated using graphpad prism - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ic 50 calculation model in graphpad prism 5  (GraphPad Software Inc)
    90
    GraphPad Software Inc ic 50 calculation model in graphpad prism 5
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Calculation Model In Graphpad Prism 5, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic 50 calculation model in graphpad prism 5/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic 50 calculation model in graphpad prism 5 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ic 50 calculation software graphpad prism 5 version 5.01  (GraphPad Software Inc)
    90
    GraphPad Software Inc ic 50 calculation software graphpad prism 5 version 5.01
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Calculation Software Graphpad Prism 5 Version 5.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic 50 calculation software graphpad prism 5 version 5.01/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic 50 calculation software graphpad prism 5 version 5.01 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ic 50 calculation software graphpad prism version 6.05  (GraphPad Software Inc)
    90
    GraphPad Software Inc ic 50 calculation software graphpad prism version 6.05
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Calculation Software Graphpad Prism Version 6.05, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic 50 calculation software graphpad prism version 6.05/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic 50 calculation software graphpad prism version 6.05 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ic 50 calculation by nonlinear regression using graphpad prism v5.0  (GraphPad Software Inc)
    90
    GraphPad Software Inc ic 50 calculation by nonlinear regression using graphpad prism v5.0
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Calculation By Nonlinear Regression Using Graphpad Prism V5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic 50 calculation by nonlinear regression using graphpad prism v5.0/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic 50 calculation by nonlinear regression using graphpad prism v5.0 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    confidence intervals of proportions, ec 50 , and ic 50 values calculated with graphpad prism 6  (GraphPad Software Inc)
    90
    GraphPad Software Inc confidence intervals of proportions, ec 50 , and ic 50 values calculated with graphpad prism 6
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Confidence Intervals Of Proportions, Ec 50 , And Ic 50 Values Calculated With Graphpad Prism 6, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/confidence intervals of proportions, ec 50 , and ic 50 values calculated with graphpad prism 6/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    confidence intervals of proportions, ec 50 , and ic 50 values calculated with graphpad prism 6 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ic 50 calculation option of graphpad prism 4 software  (GraphPad Software Inc)
    90
    GraphPad Software Inc ic 50 calculation option of graphpad prism 4 software
    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of <t>sacituzumab</t> (anti-TROP2 antibody) or sacituzumab <t>govitecan</t> (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.
    Ic 50 Calculation Option Of Graphpad Prism 4 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ic 50 calculation option of graphpad prism 4 software/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    ic 50 calculation option of graphpad prism 4 software - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of sacituzumab (anti-TROP2 antibody) or sacituzumab govitecan (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.

    Journal: Scientific Reports

    Article Title: A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan

    doi: 10.1038/s41598-024-84566-y

    Figure Lengend Snippet: Effect of TROP2-targeted ADC on proliferation of KS-EMPD-1 cells. KS-EMPD-1 cells were treated with vehicle control (PBS) or various concentrations (0.1–100 μM) of sacituzumab (anti-TROP2 antibody) or sacituzumab govitecan (TROP2-targeted ADC) for 48 h. Then, viable cells were quantified using CCK-8 solution. Experiments were performed in triplicate wells and independently repeated three times. Mean ± SD of fold change of viable cells is shown. *** p < 0.001.

    Article Snippet: IC 50 of sacituzumab govitecan was calculated with GraphPad Prism 7 software (GraphPad Software, San Diego, CA).

    Techniques: Control, CCK-8 Assay